GLYCAN AND GLYCOPROTEIN SEPARATIONS

More than two thirds of recombinant biopharmaceutical products on the market are glycoproteins, and nearly every stage of their manufacture is carefully monitored and regulated to ensure consistency in quality, safety, and effectiveness. Consequently, international regulatory agencies require use of state-of-the-art glycan analyses methods to help ensure the successful development and commercialization of effective and safe glycosylated biotherapeutics. To address this need, Waters offers a variety of robust, reproducible, complementary, information-rich analytical methods for this application.